Results 221 to 230 of about 572,911 (283)

Age‐Adjusted Charlson Comorbidities Index for Survival Prognosis in Laryngeal Squamous Cell Carcinoma Patients

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective This study aimed to explore the prognostic relevance of the age‐adjusted Charlson Comorbidity Index (ACCI) in laryngeal squamous cell carcinoma (LSCC) survival. Methods This retrospective analysis was conducted on the medical records of 367 LSCC patients admitted to the First Hospital of Shanxi Medical University, China, from January
Ze‐Hui Gao   +5 more
wiley   +1 more source

GAS‐J, a User‐Friendly Browser Application for Genome Assembly, emm‐Typing, MLST Typing, and Virulence Factor Gene Detection of Streptococcus pyogenes

open access: yesMicrobiology and Immunology, EarlyView.
ABSTRACT Clinical isolates of Streptococcus pyogenes are usually classified using emm and multilocus sequence typing (MLST). Recently, whole genome sequencing (WGS) has been employed for emm typing and MLST analysis. WGS data provides additional information on the presence of virulence factor genes.
Norihiko Takemoto   +10 more
wiley   +1 more source

Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC‐2): A randomised controlled trial

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
Abstract Objective To investigate the efficacy of imiquimod in women with residual or recurrent cervical intraepithelial neoplasia (rrCIN), compared with large loop excision of the transformation zone (LLETZ). Design Randomised controlled non‐inferiority trial. Setting One academic and one regional hospital in the Netherlands.
Anna J. M. van de Sande   +11 more
wiley   +1 more source

Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening. [PDF]

open access: yesEur J Hum Genet
Raspa M   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy